Surgical Robots Market 2019 | Develop Rapidly by Players Think Surgical, TranEnterix, Zimmer Biomet, Stryker Corporation, Smith & Nephew, and Medrobotics Corporation

Major manufacturers are focused on collaborations and mergers and acquisitions in surgical robots market and are actively investing in the research and development of robotic systems. For instance, collaboration of Johnson & Johnson and Google, to form Verb Surgical, Inc. In 2015.

Furthermore, Cambridge Medical Robotics (CMR) — a U.K.-based manufacturer — is researching on more versatile, affordable next generation surgical robots, for improving minimally invasive surgeries. CMR’s first robot has five self-contained robotic arms attached to a slim and modular system. Each arm has an intelligence and sensing systems to function as per surgeons commands and the arms are customizable.

Request Sample Copy of This Report: https://www.coherentmarketinsights.com/insight/request-sample/496

For instance, Stryker acquired Mako Surgical Robotic Systems for US$ 1.65 Bn in 2013 and in 2016, it launched Mako surgical robots for total knee replacement. Furthermore, in 2015, TransEnterix acquired SOFAR Surgical Robotics unit for US$ 100 Mn. In 2016, Zimmer Biomet Holding Inc. acquired surgical robotics provider, Medtech SA, for US$ 132 Mn to increase its portfolio and in 2016, MEDTECH received clearance from the U.S. Food and Drug Administration (FDA) to market the ROSA Spine robot in the U.S.

Furthermore, in 2013, Auris Surgical Robotics acquired Hassen Medical, as the Hassen Medical specialized in intravascular robotic catheter systems. In 2016, the FDA granted 510(k) clearance to the Ares robot-assisted bronchoscopy platform developed by stealthy Auris Surgical Robotics

In 2015, Smith & Nephew — a British-based orthopedics giant — expanded its foothold in the surgical robotics market by acquiring Blue Belt Technologies and its Navio robotics system, which is a U.S.-based company.

Increasing US Food and Drug Administration approval for surgical robots is also expected to favor growth of surgical robots market. For instance, in October 2017, US Food and Drug Administration (FDA) approved the Senhance system, of TransEnterix, which is a robotically assisted surgical device for minimally invasive surgeries. In 2016, U.S. FDA approved the first medical robot from Auris Surgical — a startup led by the co-founder of Intuitive Surgical — a developer of Da Vinci robots.

Get PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/496

Furthermore, Stryker received FDA approval in August 2015, however, delayed its worldwide sales until 2017, and so MAKO RIO was used only in 65 hospitals in the U.S., the U.K., Australia, and Germany from 2015 –2017. In 2014, ROBODOC Encore Surgical System received 510(k) clearance from the US Food and Drug Administration (FDA) for total hip Arthroplasty procedures.

Some major players operating in the global surgical robots market includes Intutitive Surgical, Think Surgical, TransEnterix, Zimmer Biomet, Stryker Corporation, Smith & Nephew, and Medrobotics Corporation.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.